Evidera’s biannual publication focused on the scientific, strategic, and operational challenges of today’s healthcare environment. This issue highlights a variety of topics to address our industry’s most pressing issues, such as working in the era of COVID-19, continuing to engage patients and their preferences in drug development, and understanding the latest insights and guidance from industry stakeholders.

In This Issue

• Digital Approaches in the Era of COVID-19: Interviews with Science 37 and Medable
• Leveraging Decentralized RWE Data Collection Strategies during the COVID-19 Pandemic and Beyond
• A Systematic Approach to Assessing Real-World Research Questions Supported by Digital Enablement
• Leveraging Simulation to Patch a Clinical Trial Broken by COVID-19
• Evidence Generation Using Innovative, Technology-Driven Data Collection
• Surprises You Don’t Want When Adopting eCOAs for Use in Clinical Trials: Cautions for Decision Making and Planning
• Digital Therapeutics: Past Trends and Future Prospects
• US FDA’s Emergency Use Authorization (EUA): Applicability for Marketed and/or Investigational Products for Treatment of COVID-19
• Integrated Scientific Advice during the COVID-19 Pandemic
• Trends in Medical Device Purchasing, Evaluation of Value, and Advice for Manufacturers: An Interview with Vizient
• Patient Preference Studies in HTA Decision Making: A NICE to Have?
• Version 4.1 of the AMCP Format: Introducing a Trio of Dossiers to Support a Product Throughout its Lifecycle

Click here to read the full issue, access past issues, and subscribe to news about upcoming issues